Clinical Trial Update: Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy (PEACE) [Phase 3]

View source ↗

Summary

Phase 3 PEACE trial evaluated whether ACE inhibitor therapy with trandolapril reduces cardiovascular events in patients with stable coronary disease. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Coronary Artery Disease
• Heart Disease
• Myocardial Infarction
• Myocardial Ischemia

Drugs mentioned

• Trandolapril (trandolapril)

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED